Fresenius Medical Care
FMS · NYSE
Bulios Fair Price
$32.7
46.6% upside
Preț actual
$22.3
Potrivit Bulios Fair Price, acțiunile FMS sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Bulios Fair Price este o estimare a valorii corecte a unei acțiuni din modelul de evaluare Bulios. Este un punct de plecare pentru propria analiză, nu o recomandare de investiții. Cum funcționează?
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Despre companie
Fresenius Medical Care AG & Co. KGaA (FME) is a German company specializing in providing dialysis and other medical services for patients with chronic kidney failure. Their portfolio includes a wide range of products and services in the field of dialysis, including hemodialysis, peritoneal dialysis, dialysis machines, dialysis supplies, and clinical consulting. Fresenius Medical Care focuses on providing high-quality care and innovative solutions for patients with kidney disease to improve their quality of life and health. The company also invests in research and development of new dialysis technologies and treatment methods to continuously innovate and improve its products and services. Fresenius Medical Care AG & Co. KGaA (FME) shares may be attractive to investors seeking investments in companies operating in the healthcare services field with an emphasis on caring for patients with chronic kidney failure and innovation in healthcare.
Nu este încă disponibil în limba dumneavoastră, așa că textul este în engleză.
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Helen Giza
Employees
108,165
Headquarters
Bad Homburg
Evenimente viitoare
Earnings
Upcoming earnings report